Skip to main content
Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
44.09
+0.47 (1.08%)
Nov 20, 2024, 4:00 PM EST - Market closed

Amphastar Pharmaceuticals Revenue

Amphastar Pharmaceuticals had revenue of $191.21M in the quarter ending September 30, 2024, with 5.90% growth. This brings the company's revenue in the last twelve months to $723.55M, up 20.33% year-over-year. In the year 2023, Amphastar Pharmaceuticals had annual revenue of $644.40M with 29.14% growth.

Revenue (ttm)
$723.55M
Revenue Growth
+20.33%
P/S Ratio
2.95
Revenue / Employee
$410,874
Employees
1,761
Market Cap
2.12B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023644.40M145.41M29.14%
Dec 31, 2022498.99M61.22M13.98%
Dec 31, 2021437.77M87.92M25.13%
Dec 31, 2020349.85M27.49M8.53%
Dec 31, 2019322.36M27.69M9.40%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Alignment Healthcare 2.47B
Astrana Health 1.72B
Premier 1.33B
CONMED 1.29B
Addus HomeCare 1.13B
Omnicell 1.06B
UFP Technologies 461.85M
Ligand Pharmaceuticals 152.42M
Revenue Rankings

AMPH News

More News